Merit Medical Q2 revenue up 10% to $418.8M; GAAP EPS $0.65, up 20% YoY; updates FY2026 guidance

MERIT MEDICAL SYSTEMS INC

Revenue $418.8M, +10% YoY; constant currency revenue +9%, organic constant currency revenue +9%.
GAAP operating margin 14.4% vs 12.3%; non-GAAP operating margin 22.6% vs 21.2%.
GAAP EPS $0.65 (+20%); non-GAAP EPS $1.19 (+18%).
YTD cash from operations $110.0M (-11%); free cash flow $76.6M (-14%).
Full-year 2026 guidance updated; specific figures not provided in excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.